Insider Screener
Real-time Form 4 Filtering Engine
| Filing Date | Trade Date | Ticker | Company Name | Reporting Person | Relationship | Industry (by SEC) | Type | Price | Qty | Total, $ | Owned After | Change, % |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-01-14 01:08 | 2021-01-12 | CVS | CVS HEALTH Corp | Bisaccia Lisa | Officer; EVP and Chief HR Officer | Retail-Drug Stores and Proprietary Stores | OPT+S | $77.00 | 25,177 | $1,938,629 | 46,588 | -35.1% |
| 2018-10-03 23:07 | 2018-10-01 | CVS | CVS HEALTH Corp | Bisaccia Lisa | Officer; EVP and Chief HR Officer | Retail-Drug Stores and Proprietary Stores | OPT+S | $80.00 | 21,534 | $1,722,720 | 21,086 | -50.5% |
| 2017-12-23 00:39 | 2017-12-21 | CVS | CVS HEALTH Corp | Bisaccia Lisa | Officer; EVP and Chief HR Officer | Retail-Drug Stores and Proprietary Stores | SALE | $75.00 | 29,445 | $2,208,375 | 15,556 | -65.4% |
| 2015-07-16 23:31 | 2015-07-15 | CVS | CVS HEALTH Corp | Bisaccia Lisa | Officer; EVP, Chief HR Officer | Retail-Drug Stores and Proprietary Stores | OPT+S | $110.00 | 49,908 | $5,489,950 | 21,003 | -70.4% |
| 2014-10-28 23:07 | 2014-10-27 | CVS | CVS HEALTH Corp | Bisaccia Lisa | Officer; SVP, Chief HR Officer | Retail-Drug Stores and Proprietary Stores | OPT+S | $85.00 | 33,507 | $2,848,095 | 17,281 | -66.0% |
| 2013-12-11 23:41 | 2013-12-10 | CVS | CVS HEALTH Corp | Bisaccia Lisa | Officer; SVP, Chief HR Officer | Retail-Drug Stores and Proprietary Stores | OPT+S | $68.00 | 12,057 | $819,876 | 8,476 | -58.7% |
| 2013-11-26 00:03 | 2013-11-21 | CVS | CVS HEALTH Corp | Bisaccia Lisa | Officer; SVP, Chief HR Officer | Retail-Drug Stores and Proprietary Stores | OPT+S | $66.00 | 15,299 | $1,009,734 | 8,476 | -64.3% |
| 2012-10-03 22:38 | 2012-10-01 | CVS | CVS HEALTH Corp | Bisaccia Lisa | Officer; SVP, Chief HR Officer | Retail-Drug Stores and Proprietary Stores | OPT+S | $48.42 | 56,493 | $2,735,408 | 3,147 | -94.7% |
| 2012-07-05 23:23 | 2012-07-02 | CVS | CVS HEALTH Corp | Bisaccia Lisa | Officer; SVP, Chief HR Officer | Retail-Drug Stores and Proprietary Stores | OPT+S | $47.80 | 20,633 | $986,165 | 3,147 | -86.8% |
| 2012-02-23 23:54 | 2012-02-22 | CVS | CVS HEALTH Corp | Bisaccia Lisa | Officer; SVP, Chief HR Officer | Retail-Drug Stores and Proprietary Stores | OPT+S | $43.67 | 22,693 | $991,003 | 3,590 | -86.3% |
| 2011-03-04 00:14 | 2011-03-01 | CVS | CVS HEALTH Corp | Bisaccia Lisa | Officer; SVP, Chief HR Officer | Retail-Drug Stores and Proprietary Stores | SALE | $33.04 | 3,207 | $105,959 | 0 | -100.0% |
| 2010-11-10 23:46 | 2010-11-09 | CVS | CVS HEALTH Corp | Bisaccia Lisa | Officer; SVP, Chief HR Officer | Retail-Drug Stores and Proprietary Stores | OPT+S | $31.04 | 12,381 | $384,306 | 1,004 | -92.5% |
Strategic Signal Filtering
Our screener allows you to cut through the noise of routine stock grants and small trades. By focusing on high-value transactions from C-suite executives (CEO/CFO), you can identify where the "Smart Money" is being deployed with maximum conviction.
Investing Without Illusions
Insider data is not a magic wand, but it is the most honest indicator available. While insiders sell for many reasons (taxes, personal needs), they generally buy for only one: they believe the stock price is undervalued. We provide the tools to track these skin-in-the-game moves.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.